BUZZ-Sanofi: hits record high after good cholesterol drug data

** Sanofi, already benefiting from a weaker euro, up 1.5 pct and hits all-time high following promising data on Praluent, its experimental cholesterol drug being developed with Regeneron
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.